Warning: Illegal string offset 'enable' in /home/customer/www/redhothealthcare.com/public_html/wp-content/plugins/conditional-widgets/logic.php on line 171
RED HOT Contributors


Clearside Biomedical licenses microinjector to Aura Biosciences


Clearside Biomedical, Aura BiosciencesClearside Biomedical (NSDQ:CLSD) said today that it licensed its microinjector technology to Aura Biosciences for use with Aura drug candidates in treating ocular cancers.

Alpharetta, Ga.-based Clearside’s Suprachoroidal Space Microinjector is designed to deliver therapeutics into the suprachoroidal space between the sclera and choroid of the eye. Aura, based in Cambridge, Mass., is developing viral nanoparticle conjugates designed to seek out and eliminate cancer cells.

Get the full story at our sister site, Drug Delivery Business News


We Support OUR Contributors

Comments are closed.

Get Our Newsletter

 Receive podcast updates
Exclusive insights
Patient Engagement Tips from industry experts
We hate SPAM as much as you do and promise to keep your email address safe.
  • Subscribe to the Podcast